Astrocyte activation and neuroinflammatory signaling

Astrocyte activation and neuroinflammatory signaling refers to the complex physiological response of astrocytes to central nervous system (CNS) insults, a process known as reactive astrogliosis. In response to injury or neurodegeneration, astrocytes undergo significant changes in gene expression and morphology, releasing a variety of signaling molecules including cytokines like TNF-alpha and IL-1, chemokines, and reactive oxygen species (Liddelow et al., Nature, 2017). While acute activation can be neuroprotective by forming a glial scar to contain damage, chronic activation is a primary driver of neuroinflammation and neuronal death in diseases like Alzheimer's and Parkinson's (Glass et al., Cell, 2010). This signaling cascade involves the activation of various intracellular pathways, such as the NF-kB and JAK/STAT3 pathways, which regulate the production of inflammatory mediators (Yun et al., Frontiers in Molecular Neuroscience, 2018). Therapeutic interventions targeting this process often focus on specific molecular components within the signaling cascade to mitigate the transition of astrocytes into a neurotoxic phenotype. Monitoring this process in clinical settings often involves measuring biomarkers like Glial Fibrillary Acidic Protein (GFAP) in the blood or cerebrospinal fluid (Abdelhak et al., Nature Reviews Neurology, 2022). Because this term describes a broad biological phenomenon involving multiple cell types and molecular pathways, it is classified as a biological process rather than a single discrete therapeutic target molecule.

Other names

Reactive astrogliosisAstrocyte reactivityGlial activationNeuroinflammationAstrocyte-mediated neurotoxicity

Inhibition of pro-inflammatory cytokine release and modulation of reactive astrocyte phenotypes from neurotoxic (A1) to neuroprotective (A2) states.